Schizophrenia News

  • AAGP 2018 Schizophrenia Drug Reduces Alzheimer's-Related Agitation Brexpiprazole, approved by the FDA in 2015 to treat schizophrenia and depression, is also effective for treating agitation in patients with Alzheimer's-related dementia, two phase 3 trials suggest.
  • Lifestyle Linked to Brain Health in Psychosis Patients Just as in the general population, patients with schizophrenia and bipolar disorder should follow a healthy lifestyle, which includes being physically and cognitively active.

Schizophrenia Perspective

  • EPA 2018 Read clinically focused news coverage of key developments from EPA 2018
  • Prevent Schizophrenia Relapse With Regular Maintenance   Dr Peter Yellowlees discusses 1-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo.